EagleNXT Reports Third Quarter Fiscal Year 2025 Financial Results and Highlights Key Operational Developments

Stock Information for Oncternal Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Oncternal Therapeutics Inc.

EagleNXT Commences Deliveries with Vyom Drones to Serve India's Growing Unmanned Vehicle Demands
EagleNXT Achieves ANATEL Certification Renewal for eBee X Drone Operations in Brazil 
AgEagle Aerial Systems Inc Announces Entry to Purchases Sales Agreement up to $100,000,000 Series G
Commercial UAV Market Expected to Reach $7.64 Trillion By 2034 as Global Growth Outlook is Strong
EagleNXT Announces Sale of eBee VISION Drones to U.S. Army's 1st Battalion, 4th Infantry Regiment in Germany
EagleNXT Partners with Makville to Bring Cutting-Edge Drones to Egypt
EagleNXT Announces Sale of Advanced eBee TAC Drones to Defense Logistics Agency
EagleNXT Debuts MicaSense RedEdge-P Triple: A Game-Changer for Precision Drone Imaging

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.